Edition:
India

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

11.72USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$11.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
219,174
52-wk High
$25.95
52-wk Low
$5.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.58 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 3 3 1
(3) HOLD 2 3 3 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.29 2.29 2.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.00 0.00 0.00 0.19
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Year Ending Dec-17 5 0.00 0.00 0.00 0.42
Year Ending Dec-18 5 0.00 0.00 0.00 0.30
Earnings (per share)
Quarter Ending Dec-17 5 -0.58 -0.45 -0.66 -0.62
Quarter Ending Mar-18 4 -0.75 -0.59 -1.12 --
Year Ending Dec-17 5 -2.50 -2.31 -2.71 -2.51
Year Ending Dec-18 5 -2.74 -1.96 -4.24 -2.56

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.03 0.00 0.03 100.00
Quarter Ending Jun-17 0.05 0.00 0.05 100.00
Quarter Ending Mar-17 0.08 0.00 0.08 100.00
Quarter Ending Dec-16 0.00 0.00 0.00 100.00
Quarter Ending Sep-16 0.08 0.00 0.08 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00 0.19
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-17 0.00 0.05 0.04 0.04 0.42
Year Ending Dec-18 0.00 0.05 0.61 0.61 0.30

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings